Series A - Beckley Psytech

Series A - Beckley Psytech

Investment Firm

Overview

Beckley Psytech is a clinical-stage biotechnology company that explores the therapeutic potential of psychedelic substances.

Announced Date

Jun 30, 2020

Closed on Date

Nov 09, 2020

Funding Type

Series A

Highlights

Location

Europe

Social

Investor Lead

N/A

Participant Investors

5

Investor Name
Participant InvestorBicycle Day Ventures
Participant InvestorMurray Goldman
Participant InvestorOryx Ventures
Participant InvestorJamJar Investments
Participant InvestorBerti Investments

Round Details and Background

Beckley Psytech raised $14865965 on 2020-06-30 in Series A

Beckley Psytech is a clinical-stage biotechnology company that explores the therapeutic potential of psychedelic substances.

Company Funding History

7

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
May 01, 2021
Series B - Beckley Psytech
2-undefined
Aug 15, 2021
Series B - Beckley Psytech
14-80.4M
Jan 04, 2024
Corporate Round - Beckley Psytech
1-40.0M
Jan 04, 2024
Secondary Market - Beckley Psytech
1-10.0M

Recent Activity

There is no recent news or activity for this profile.